isis pharmaceuticals inc
B. Lynne Parshall Esq., J.D.
Chief Operating Officer, Secretary and Director, Isis Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 50 board members in 4 different organizations across 5 different industries.|
See Board Relationships
As of Fiscal Year 2012
Ms. B. Lynne Parshall, Esq., J.D. has been the Chief Operating Officer of Isis Pharmaceuticals, Inc. since December 2007 and also serves as its Secretary. Ms. Parshall served as Chief Financial Officer since June 1994 and also serves as its Principal Accounting Officer and Secretary. Ms. Parshall is responsible for overseeing the operations of finance, legal, patents, manufacturing and business development and is also involved in Isis Pharmaceuticals, Inc.’s corporate ...
Corporate Headquarters*2855 Gazelle Court
Carlsbad, California 92010
Board Members Memberships*
Chief Operating Officer, Secretary and Director
Director, Chairman of Audit Committee and Member of Nominating & Governance Committee
Former Director and Chairman of Audit Committee
Director and Chairman of Audit Committee
Director and Member of Audit Committee
Stanford University Law school
|George W. Hebard III, M.B.A||Interim Principal Executive Officer, Interim Chief Operating Officer and Director|
Enzon Pharmaceuticals Inc.
|Christopher Nishan Garabedian||Chief Executive Officer, President and Director|
Sarepta Therapeutics, Inc.
|John M. Maraganore Ph.D.||Chief Executive Officer and Executive Director|
Alnylam Pharmaceuticals, Inc.
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|$515.5K||Compensation as of Fiscal Year 2012.|